This process leads to a decrease in PKM2 activity, accumulation of glycolytic intermediates, and stimulation of amino acid biosynthesis, pentose phosphate pathway, and nucleotide synthesis metabolism, ultimately driving tumor cell growth [152,153]. This evidence concerns the gene PKM and neoplasm.